Low 25-OH Vitamin D is Associated with Benign Prostatic Hyperplasia-Reference-Cited by-同舟云学术

Low 25-OH Vitamin D is Associated with Benign Prostatic Hyperplasia

Published:2013-08 Issue:2 Volume:190 Page:608-614
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Haghsheno Mohammad-Ali¹,Mellström Dan²,Behre Carl-Johan³,Damber Jan-Erik¹,Johansson Helena²,Karlsson Magnus⁴,Lorentzon Mattias²,Peeker Ralph¹,Barret-Connor Elisabet⁵,Waern Ewa²,Sundh Valter⁶,Ohlsson Claes²,Hammarsten Jan⁷

Affiliation:

1. Department of Urology, Institute of Clinical Sciences, Sahlgrenska University Hospital, Goteborg, Sweden

2. Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Sahlgrenska University Hospital, Goteborg, Sweden

3. Department of Internal Medicine, Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden

4. Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences and Orthopaedic Surgery, Skåne University Hospital in Malmö, Lund University, Malmö, Sweden

5. Department of Family and Preventive Medicine, University of California-San Diego, San Diego, California

6. Department of Community Medicine and Public Health, Sahlgrenska University Hospital, Goteborg, Sweden

7. Section of Urology, Department of Surgery, Karlstad Central Hospital, Karlstad, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Correlation between benign prostatic hyperplasia and inflammation;Bostanci;Curr Opin Urol,2013

2. The correlation between metabolic syndrome and prostatic diseases;De Nunzio;Eur Urol,2012

3. Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasia;Hammarsten;Prostate Cancer Prostatic Dis,1998

4. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia;Ozden;Eur Urol,2007

5. Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia;Hammarsten;Prostate Cancer Prostatic Dis,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of efficacy of cholecalciferol and silymarin in improving lower urinary tract symptoms of benign prostatic hyperplasia: A double-blind, randomized, controlled trial;Urologia Journal;2024-09-02

2. Association of serum 25-hydroxyvitamin D with urinary incontinence in elderly men: evidence based on NHANES 2007-2014;Frontiers in Endocrinology;2023-09-08

3. Genetically predicted alterations in thyroid function are associated with the risk of benign prostatic disease;Frontiers in Endocrinology;2023-04-17

4. Anemia is associated with increased risk of non-vertebral osteoporotic fractures in elderly men: the MrOS Sweden cohort;Archives of Osteoporosis;2022-06-23

5. Nutritional supplementation of the pharmacotherapy of prostate diseases;Research Results in Pharmacology;2021-07-07